Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Biomarkers  [Clear All Filters]
1995
Ghaddar HB, Cortes J, Salomaa V, et al. "Correlation of specific platelet activation markers with carotid arterial wall thickness." Thromb Haemost. 1995;74(3):943-8.
2001
Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H. "Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb Vasc Biol. 2001;21(4):611-7.
2003
Folsom AR, Desvarieux M, Nieto JF, Boland LL, Ballantyne CM. "B vitamin status and inflammatory markers." Atherosclerosis. 2003;169(1):169-74.
Chambless LE, Folsom AR, Sharrett ARichey, Sorlie P, Couper DJ, Szklo M. "Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study." J Clin Epidemiol. 2003;56(9):880-90.
Duncan BB, Schmidt M I, Chambless LE, Folsom AR. "Inflammation markers predict increased weight gain in smoking quitters." Obes Res. 2003;11(11):1339-44.
Folsom AR, Cushman M, Heckbert SR, Rosamond WD. "Prospective study of fibrinolytic markers and venous thromboembolism." J Clin Epidemiol. 2003;56(6):598-603.
2007
Reich LM, Heiss G, Boland LL, Hirsch AT, Wu K. "Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort." Vasc Med. 2007;12(4):267-73.
Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D. "Early-life and adult socioeconomic status and inflammatory risk markers in adulthood." Eur J Epidemiol. 2007;22(1):55-66.
Vigo A, Duncan BB, Schmidt MI, Couper DJ, Heiss G, Pankow JS. "Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities Study." Braz J Med Biol Res. 2007;40(7):933-41.
2008
Catellier DJ, Aleksic N, Folsom AR. "Atherosclerosis Risk in Communities (ARIC) Carotid MRI flow cytometry study of monocyte and platelet markers: intraindividual variability and reliability." Clin Chem. 2008;54(8):1363-71.
Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D. "Cumulative life course and adult socioeconomic status and markers of inflammation in adulthood." J Epidemiol Community Health. 2008;62(6):484-91.
Lee CR, North KE, Bray MS, Couper DJ, Heiss G. "Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study." Clin Pharmacol Ther. 2008;83(1):52-60.
Kucharska-Newton AMaria, Rosamond WD, Mink PJ, Alberg AJ, Shahar E. "HDL-cholesterol and incidence of breast cancer in the ARIC cohort study." Ann Epidemiol. 2008;18(9):671-7.
Sturgeon JD, Folsom AR, Longstreth WT, Shahar E, Rosamond WD. "Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort." Stroke. 2008;39(8):2268-73.
Pankow JS, Boerwinkle E, Adams PC, Guallar E, Leiendecker-Foster C, Rogowski J. "HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study." Transl Res. 2008;152(1):3-10.
Nambi V, Morrison AC, Hoogeveen RC, et al. "Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study." Tex Heart Inst J. 2008;35(4):388-94.
2009
Folsom AR, Lutsey PL, Astor BC. "C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort." Thromb Haemost. 2009;102(4):615-9.
Bash LD, Coresh JJ, Köttgen A, Parekh RS, Fulop T, Wang Y. "Defining incident chronic kidney disease in the research setting: The ARIC Study." Am J Epidemiol. 2009;170(4):414-24.
Kucharska-Newton AMaria, Couper DJ, Pankow JS, et al. "Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort." Arterioscler Thromb Vasc Biol. 2009;29(12):2182-90.
Gottesman RF, Cummiskey C, Chambless L, Wu KK, Aleksic N, Folsom AR. "Hemostatic factors and subclinical brain infarction in a community-based sample: the ARIC study." Cerebrovasc Dis. 2009;28(6):589-94.
Bash LD, Erlinger TP, Coresh JJ, Marsh-Manzi J, Folsom AR. "Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2009;53(4):596-605.
Nambi V, Hoogeveen RC, Chambless L, et al. "Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2009;40(2):376-81.
Pellanda LC, Duncan BB, Vigo A, Rose K, Folsom AR. "Low birth weight and markers of inflammation and endothelial activation in adulthood: the ARIC study." Int J Cardiol. 2009;134(3):371-7.
McGeechan K, Liew G, Macaskill P, et al. "Meta-analysis: retinal vessel caliber and risk for coronary heart disease." Ann Intern Med. 2009;151(6):404-13.
Lutsey PL, Folsom AR, Heckbert SR. "Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study." J Thromb Haemost. 2009;7(10):1639-48.
Chen H, Mosley TH, Alonso A, Huang X. "Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study." Am J Epidemiol. 2009;169(9):1064-9.
Breslow NE, Lumley T, Ballantyne CM, Chambless LE. "Using the whole cohort in the analysis of case-cohort data." Am J Epidemiol. 2009;169(11):1398-405.
2010
Gaubatz JW, Ballantyne CM, Wasserman BA, He M, Chambless LE, Boerwinkle E. "Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI Study." Arterioscler Thromb Vasc Biol. 2010;30(5):1034-42.
Nettleton JA, Matijevic N, Follis JL, Folsom AR. "Associations between dietary patterns and flow cytometry-measured biomarkers of inflammation and cellular activation in the Atherosclerosis Risk in Communities (ARIC) Carotid Artery MRI Study." Atherosclerosis. 2010;212(1):260-7.
Yeung EH, Saudek CD, Jahren HA, et al. "Evaluation of a novel isotope biomarker for dietary consumption of sweets." Am J Epidemiol. 2010;172(9):1045-52.
Suri FMK, Yamagishi K, Aleksic N, Hannan PJ. "Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study." Cerebrovasc Dis. 2010;29(5):497-502.
Folsom AR, Lutsey PL, Heckbert SR. "Serum albumin and risk of venous thromboembolism." Thromb Haemost. 2010;104(1):100-4.
Zakai NA, Lutsey PL, Folsom AR, Heckbert SR. "Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology." Thromb Haemost. 2010;104(2):207-12.
2011
Matijevic N, Wu KK, Nidkarni N, Heiss G. "The ARIC carotid MRI study of blood cellular markers: an inverse association of monocyte myeloperoxidase content with peripheral arterial disease." Angiology. 2011;62(3):237-44.
Matijevic N, Wu KK, Howard AG, Wasserman B, Wang WY-W, Folsom AR. "Association of blood monocyte and platelet markers with carotid artery characteristics: the atherosclerosis risk in communities carotid MRI study." Cerebrovasc Dis. 2011;31(6):552-8.
Muntner P, Lee F. "Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study." Am J Med Sci. 2011;341(3):173-80.
Prizment AE, Anderson KE, Visvanathan K. "Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study." Cancer Epidemiol Biomarkers Prev. 2011;20(2):297-307.
Kucharska-Newton AMaria, Monda KL, Campbell S, et al. "Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2011;216(1):151-6.
Saunders JT, Nambi V, de Lemos JA, et al. "Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study." Circulation. 2011;123(13):1367-76.
van der Velde M, Matsushita K, Coresh JJ, et al. "Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts." Kidney Int. 2011;79(12):1341-52.
O'Seaghdha CM, Hwang S-J, Bhavsar NA, Köttgen A, Coresh JJ, Astor BC. "Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population." Am J Kidney Dis. 2011;57(6):841-9.
Dehghan A, Dupuis J, Barbalic M, et al. "Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels." Circulation. 2011;123(7):731-8.
Virani SS, Catellier DJ, Pompeii LA, et al. "Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study." Atherosclerosis. 2011;219(2):596-602.
Agarwal SK, Avery CL, Ballantyne CM, et al. "Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study." Clin Chem. 2011;57(6):891-7.
Astor BC, Köttgen A, Hwang S-J, Bhavsar N, Fox CS. "Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study." Am J Nephrol. 2011;34(4):291-7.
2012
Juraschek SP, Steffes MW, Miller ER. "Alternative markers of hyperglycemia and risk of diabetes." Diabetes Care. 2012;35(11):2265-70.
Norby FL, Agarwal SK, Maclehose RF, et al. "Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study." Circ Arrhythm Electrophysiol. 2012;5(1):155-62.
Rubin J, Matsushita K, Ballantyne CM, Hoogeveen RC, Coresh JJ. "Chronic hyperglycemia and subclinical myocardial injury." J Am Coll Cardiol. 2012;59(5):484-9.
Kaptoge S, Di Angelantonio E, Pennells L, et al. "C-reactive protein, fibrinogen, and cardiovascular disease prediction." N Engl J Med. 2012;367(14):1310-20.
Folsom AR, Nambi V, Pankow JS, Tang W, Farbakhsh K, Yamagishi K. "Effect of 9p21 genetic variation on coronary heart disease is not modified by other risk markers. The Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2012;224(2):435-9.
Alonso A, Tang W, Agarwal SK, Soliman EZ, Chamberlain AM. "Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study." Int J Cardiol. 2012;155(2):217-22.
Avery CL, Kucharska-Newton AMaria, Monda KL, et al. "Impact of long-term measures of glucose and blood pressure on the retinal microvasculature." Atherosclerosis. 2012;225(2):412-7.
Bhavsar NA, Köttgen A, Coresh JJ. "Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2012;60(2):233-40.
Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA. "Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population." Am J Kidney Dis. 2012;59(5):653-62.
Voight BF, Peloso GM, Orho-Melander M, et al. "Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study." Lancet. 2012;380(9841):572-80.
Agarwal SK, Chambless LE, Ballantyne CM, et al. "Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study." Circ Heart Fail. 2012;5(4):422-9.
Hermida J, Norby FL, Montes R, Matsushita K, Astor BC. "Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study)." Am J Cardiol. 2012;109(1):95-9.

Pages